BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12009484)

  • 1. Cocaine exposure and developmental outcome from birth to 6 months.
    Behnke M; Eyler FD; Garvan CW; Wobie K; Hou W
    Neurotoxicol Teratol; 2002; 24(3):283-95. PubMed ID: 12009484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):229-37. PubMed ID: 9445496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):237-41. PubMed ID: 9445497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome from a prospective, longitudinal study of prenatal cocaine use: preschool development at 3 years of age.
    Behnke M; Eyler FD; Warner TD; Garvan CW; Hou W; Wobie K
    J Pediatr Psychol; 2006; 31(1):41-9. PubMed ID: 15827349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prenatal cocaine/crack and other drug exposure on electroencephalographic sleep studies at birth and one year.
    Scher MS; Richardson GA; Day NL
    Pediatrics; 2000 Jan; 105(1 Pt 1):39-48. PubMed ID: 10617702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal influence of prenatal cocaine exposure on child language functioning.
    Bandstra ES; Morrow CE; Vogel AL; Fifer RC; Ofir AY; Dausa AT; Xue L; Anthony JC
    Neurotoxicol Teratol; 2002; 24(3):297-308. PubMed ID: 12009485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure.
    Eyler FD; Behnke M; Garvan CW; Woods NS; Wobie K; Conlon M
    Neurotoxicol Teratol; 2001; 23(5):399-411. PubMed ID: 11711242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure.
    Bandstra ES; Morrow CE; Anthony JC; Accornero VH; Fried PA
    Neurotoxicol Teratol; 2001; 23(6):545-59. PubMed ID: 11792524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The search for congenital malformations in newborns with fetal cocaine exposure.
    Behnke M; Eyler FD; Garvan CW; Wobie K
    Pediatrics; 2001 May; 107(5):E74. PubMed ID: 11331724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.
    Lester BM; Tronick EZ; LaGasse L; Seifer R; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Lu J; Finnegan LP; Maza PL
    Pediatrics; 2002 Dec; 110(6):1182-92. PubMed ID: 12456917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample.
    Richardson GA; Hamel SC; Goldschmidt L; Day NL
    Pediatrics; 1999 Aug; 104(2):e18. PubMed ID: 10429136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight.
    Frank DA; Jacobs RR; Beeghly M; Augustyn M; Bellinger D; Cabral H; Heeren T
    Pediatrics; 2002 Dec; 110(6):1143-52. PubMed ID: 12456912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cocaine/polydrug exposure and maternal psychological distress on infant birth outcomes.
    Singer LT; Salvator A; Arendt R; Minnes S; Farkas K; Kliegman R
    Neurotoxicol Teratol; 2002; 24(2):127-35. PubMed ID: 11943500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infant Behaviors, Prenatal Cocaine Exposure, and Adult Intelligence.
    Singer LT; Albert JM; Minnes S; Min MO; Kim JY
    JAMA Netw Open; 2024 May; 7(5):e2411905. PubMed ID: 38758554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.
    Serino Ma D; Peterson Md BS; Rosen Md TS
    J Dual Diagn; 2018; 14(3):158-170. PubMed ID: 29694295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrimental effects of prenatal cocaine exposure: illusion or reality?
    Richardson GA; Day NL
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):28-34. PubMed ID: 8138518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine growth of full-term infants: impact of prenatal cocaine exposure.
    Bandstra ES; Morrow CE; Anthony JC; Churchill SS; Chitwood DC; Steele BW; Ofir AY; Xue L
    Pediatrics; 2001 Dec; 108(6):1309-19. PubMed ID: 11731653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of prenatal cocaine exposure and infant-caregiver attachment behavior.
    Beeghly M; Frank DA; Rose-Jacobs R; Cabral H; Tronick E
    Neurotoxicol Teratol; 2003; 25(1):23-38. PubMed ID: 12633734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response effect of cocaine on newborn head circumference.
    Bateman DA; Chiriboga CA
    Pediatrics; 2000 Sep; 106(3):E33. PubMed ID: 10969117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women.
    Macmillan C; Magder LS; Brouwers P; Chase C; Hittelman J; Lasky T; Malee K; Mellins CA; Velez-Borras J
    Neurology; 2001 Oct; 57(8):1402-11. PubMed ID: 11673580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.